Contact
Please use this form to send email to PR contact of this press release:
Cytonome Congratulates Sumitomo Pharma on Regulatory Approval for Regenerative Medicine Therapy for Parkinson’s disease
TO:
John Sharpe
Cytonome-ST LLC
+1 617-866-8850